Journal
AUTOIMMUNITY REVIEWS
Volume 13, Issue 2, Pages 114-116Publisher
ELSEVIER
DOI: 10.1016/j.autrev.2013.09.011
Keywords
Inflammatory bowel disease; Multiple sclerosis; Th17 cells; Blood brain barrier
Categories
Ask authors/readers for more resources
Inflammatory bowel disease (IBD) and multiple sclerosis (MS) are autoimmune diseases with a close relationship to their disease pattern add immunologic cascade with considerable morbidity and mortality. This article provides insight of why tumor necrosis factor blockers couldn't work in multiple sclerosis and why interferon-beta doesn't work in inflammatory bowel disease. In this article, we provide a detailed review of the linkage and potential interchangeable medication between IBD and MS in addition to Natalizumab, Trichuris suis egg therapy and vitamin D. Different treatment strategies may have potential in treating both diseases in the future. Published by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available